What the omega-3 index actually measures
The omega-3 index is the percentage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in red blood cell membranes, expressed as a percentage of total fatty acids. It was proposed as a cardiovascular risk factor in 2004 by William Harris and Clemens von Schacky, based on a growing body of evidence linking red blood cell omega-3 content to cardiac outcomes[1].
Why red blood cells? Because they turn over every 120 days, making them a stable reflection of your average omega-3 intake over the previous 2-3 months. This is the same logic behind HbA1c for blood sugar. A single serum measurement of EPA and DHA fluctuates with meals; the red blood cell measurement gives you the long view.
The test is straightforward. It can be done from a standard blood draw or even a dried blood spot. Labs measure the fatty acid composition of red blood cell membranes and express EPA+DHA as a percentage of total fatty acids.
The risk zones: below 4%, 4-8%, and above 8%
Harris and von Schacky defined three risk zones based on the available cardiovascular data[1]:
| Omega-3 index | Risk zone | Interpretation |
|---|---|---|
| < 4% | High risk | Significantly elevated risk of sudden cardiac death |
| 4-8% | Intermediate risk | Some protection, but not optimal |
| > 8% | Low risk (target) | Associated with lowest cardiovascular mortality |
Where do most people fall? In the United States and most of Western Europe, the average omega-3 index is between 3-5% — firmly in the intermediate-to-high-risk zone[2]. In Japan, where fatty fish consumption is dramatically higher, the average omega-3 index is approximately 8-11%, and cardiovascular mortality rates are correspondingly lower[2].
This is not a theoretical connection. The Framingham Heart Study offspring cohort followed 2,500 participants for a median of 7.3 years and found that those in the highest quintile of omega-3 index had a 34% lower risk of all-cause mortality compared to those in the lowest quintile[3]. The association remained significant after adjustment for traditional risk factors.
Cardiovascular protection: the evidence
The cardiovascular case for omega-3s — specifically EPA and DHA — rests on multiple mechanisms and multiple lines of evidence.
Sudden cardiac death
The earliest and most dramatic signal came from sudden cardiac death (SCD) data. The Physicians' Health Study, which followed over 20,000 male physicians, found that men with the highest blood levels of omega-3 fatty acids had an 81% lower risk of sudden cardiac death compared to those with the lowest levels[4]. EPA and DHA stabilize cardiac cell membranes, reducing the threshold for fatal arrhythmias. They literally make heart cells less electrically excitable in a dangerous way.
Triglycerides and atherogenic lipids
EPA and DHA are potent triglyceride-lowering agents. At doses of 2-4 grams per day, they reduce fasting triglycerides by 15-30%[5]. The REDUCE-IT trial demonstrated that 4 grams of icosapent ethyl (a purified EPA preparation) reduced major adverse cardiovascular events by 25% in statin-treated patients with elevated triglycerides[6]. This effect was likely driven by more than just triglyceride lowering — EPA also reduces arterial plaque inflammation and improves endothelial function.
Blood pressure
A meta-analysis of 70 RCTs found that omega-3 supplementation reduces systolic blood pressure by approximately 1.5 mmHg and diastolic by approximately 1.0 mmHg, with larger effects in hypertensive individuals and at doses above 2 grams per day[7]. This is a modest effect, but at a population level, even small blood pressure reductions translate into meaningful reductions in stroke and heart attack risk.
Beyond the heart: brain health and cognition
DHA is the dominant structural fatty acid in the brain, constituting approximately 15-20% of the cerebral cortex's fatty acid content and 30-60% of the retina's. It is not optional hardware — it is fundamental to neuronal membrane fluidity, synaptic signaling, and neuroplasticity[8].
Observational studies consistently link higher omega-3 levels to slower cognitive decline in aging, reduced risk of dementia, and lower rates of depression. The Framingham Heart Study found that participants in the top quartile of DHA levels had a 47% lower risk of developing all-cause dementia over a 9-year follow-up[9].
For depression, a meta-analysis of 26 RCTs found that omega-3 supplementation — particularly formulations with a higher EPA-to-DHA ratio — had a significant antidepressant effect, with an effect size comparable to some pharmaceutical interventions in mild-to-moderate depression[10].
The inflammation resolution pathway
Most people think of omega-3s as "anti-inflammatory." The reality is more nuanced and more interesting. EPA and DHA are precursors to a class of molecules called specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins. These molecules don't just block inflammation (the way an NSAID does). They actively drive the resolution of inflammation: clearing cellular debris, promoting tissue repair, and returning the immune system to homeostasis[11].
When your omega-3 index is low, you have less raw material to produce these resolution mediators. Chronic, low-grade inflammation — the kind implicated in cardiovascular disease, neurodegeneration, metabolic syndrome, and even cancer — is partly a failure of resolution, not just an excess of initiation. Higher omega-3 levels support the body's ability to turn inflammation off once it has served its purpose.
Supplementation: form matters more than you think
If your omega-3 index is below 8%, diet alone may not be sufficient unless you eat fatty fish 3-4 times per week. Most people supplement. But not all omega-3 supplements are equivalent.
Triglyceride form vs ethyl ester
Natural fish oil contains EPA and DHA in triglyceride form — attached to a glycerol backbone, the way fats exist in nature. Most concentrated fish oil supplements undergo a processing step that converts the fatty acids to ethyl esters (EE), which are cheaper to produce. Some manufacturers take the additional step of re-esterifying them back to triglyceride form (rTG).
The difference matters. A head-to-head bioavailability study found that triglyceride-form omega-3s had approximately 70% higher absorption than ethyl ester forms[12]. Another study confirmed that re-esterified triglyceride form achieved 24% higher plasma EPA+DHA levels compared to ethyl esters at the same dose[13]. Look for "triglyceride form" or "rTG" on the label.
Dosing to reach 8%
The dose required to reach an omega-3 index of 8% depends on your starting point, body weight, genetics, and how well you absorb fats. As a general framework:
- Starting index below 4%: 2,000-3,000 mg combined EPA+DHA per day
- Starting index 4-6%: 1,500-2,000 mg combined EPA+DHA per day
- Starting index 6-8%: 1,000-1,500 mg combined EPA+DHA per day
- Maintenance above 8%: 500-1,000 mg combined EPA+DHA per day, or 2-3 servings of fatty fish per week
Important: the dose that matters is combined EPA+DHA, not total fish oil. A 1,000 mg fish oil capsule typically contains only 300-500 mg of combined EPA+DHA. Read the supplement facts panel, not just the front label.
Algae oil for vegetarians and vegans
EPA and DHA in fish come from the algae the fish eat. Algae-derived omega-3 supplements provide DHA directly, and some newer formulations also include EPA. They are the only viable non-fish source of preformed DHA and are equally effective at raising the omega-3 index[14].
Take with fat
Omega-3 supplements are fat-soluble. Taking them with a meal containing fat — even a small amount of olive oil, butter, or avocado — significantly improves absorption. Taking fish oil on an empty stomach wastes a meaningful portion of the dose.
What about ALA?
Alpha-linolenic acid (ALA) — found in flaxseed, chia seeds, and walnuts — is the plant-based omega-3. Your body can convert ALA to EPA and then to DHA, but the conversion rate is extremely low: approximately 5-10% for EPA and less than 1% for DHA. ALA supplementation alone will not meaningfully raise your omega-3 index. It has its own modest health benefits, but it is not a substitute for EPA and DHA when the goal is reaching an omega-3 index above 8%.
Testing and monitoring
- Baseline: Test before starting supplementation or making dietary changes. This establishes your reference point.
- 3-4 months after starting or changing dose: Red blood cell membranes take time to reach a new steady state. Testing earlier than 3 months will not reflect your true equilibrium level.
- Once stable above 8%: Annual testing is sufficient to confirm you are maintaining optimal levels.